EUVIMEDEUVIMED entdecken
Crossref

T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop

Olga K Weinberg, Carlos E Bueso-Ramos, Rashmi Kanagal-Shamanna iD

American Journal of Clinical Pathology · 2025

DOI: 10.1093/ajcp/aqaf015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Olga K Weinberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematopathology, The University of Texas Southwestern Medical Center, Dallas, TX, United States. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The 2023 Society for Hematopathology/European Association for Hematopathology Workshop addressed advancements in the diagnosis and classification of T- and natural killer (NK)–cell lymphomas/leukemias.

Methods

Session 8 of the workshop collected a diverse set of 38 cases of immature T- and NK-cell lymphoma/leukemias, as well as acute leukemia of ambiguous lineage (ALAL) and other miscellaneous cases, including indolent T-lymphoblastic proliferations.

Results

Twenty patients with T-lymphoblastic leukemia/lymphoma (T-LBL/L) and 3 patients with early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) presented at a median age of 21.5 years. Male sex was predominant (70% of all cases), with 40% having a mediastinal mass. Cases (60%) were negative for both CD34 and TdT. In addition, 7 ALAL and 3 mixed phenotype acute leukemia, T/myeloid subtypes were submitted with a median presenting age of 16 (range, 11-56) years, and most patients (67%) frequently showed adenopathy or splenomegaly. A single case of NK acute lymphoblastic leukemia was also submitted.

Conclusions

This session highlighted unusual T-LBL/L cases with expression of cytotoxic markers, γ/δ phenotype, a more mature immunophenotype, and ALAL that are challenging to classify. Among T-ALL cases, interesting relapse changes were identified, with 1 patient developing a mature NK-cell phenotype. Patients with ALAL presented in an unusual setting of prior therapy or a germline mutation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor T-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaHumansMaleAdolescentFemaleAdultChildMiddle AgedYoung AdultKiller Cells, Natural

Stichwörter der Autor:innen

T/NK lymphoblastic leukemiaacute leukemia of ambiguous lineagegeneticsimmunophenotype

Autor:innen und Institutionen

  • Department of Hematopathology, The University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

ORCID-Profile: Rashmi Kanagal-Shamanna

Zitieren

APA

Weinberg, O. K., Bueso-Ramos, C. E., & Kanagal-Shamanna, R. (2025). T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf015

Vancouver

Weinberg OK, Bueso-Ramos CE, Kanagal-Shamanna R. T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf015

BibTeX
@article{Weinberg2025,
  author = {Weinberg, Olga K and Bueso-Ramos, Carlos E and Kanagal-Shamanna, Rashmi},
  title = {T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop},
  journal = {American Journal of Clinical Pathology},
  year = {2025},
  doi = {10.1093/ajcp/aqaf015}
}
Kostenlos starten →